Immunocore Holdings Plc (IMCR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immunocore Holdings Plc  (NASDAQ: IMCR)


Immunocore Holdings Plc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Immunocore Holdings Plc's ROI in the third quarter of 2026?
Immunocore Holdings Plc recorded a cumulative net loss of $-32 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -3.74%.

Within the Healthcare sector 205 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2708 to 2785.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -1.44 % 2.36 % 6.25 % 9.75 % 20.24 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 900 884 832 824 935
Return On Investment (TTM) -3.74 % -2.08 % -3.15 % -4 % -3.35 %
IMCR's Overall Ranking # 2785 # 2708 # 2575 # 2444 #
Seq. Investment Change TTM -1.01 % -0.87 % -1.37 % 1.82 % 2.81 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -32 -18 -28 -36 -29

IMCR Company Profile >> Back to IMCR Roi Comparisons >> See Annual IMCR Return On Investment



Return On Investment IMCR's Ranking
Within: No.
Industry # 20
Sector # 206
Overall # 2785

Return On Investment Statistics
High Average Low
-2.07 %
-3.32 %
-6.03 %
(Jun 30 2026)   (Dec 31 2024)







Financial Statements
Immunocore Holdings Plc's III. Quarter Investments $ 900 Millions IMCR's Balance sheet
Immunocore Holdings Plc's III. Quarter Income $ -14 Millions Quarterly IMCR's Income Statement
IMCR's Income by Division See IMCR's Income by Division


IMCR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 824 760 425 466 303
Y / Y Investment Growth 8.38 % 79.02 % -9 % 54.08 % 125.6 %
Net Income in Millions -36 -51 -55 -53 -181
Y / Y Net Income Growth - - - - -
Annual Return On Investment -4.31 % -6.72 % -13.02 % -11.26 % -59.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IMCR's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IMCR's Competitors
Subscribers only: Roi for Immunocore Holdings Plc's Suppliers
Subscribers only: Return On Investment for IMCR's Customers

Other Ratios
IMCR's Roa IMCR's Inventory Turnover Ratio IMCR's Growth Rates IMCR's Dividend Statistics
IMCR's Profitability Ratios IMCR's Asset Turnover Ratio IMCR's Dividend Growth
IMCR's Roe IMCR's Valuation Ratios IMCR's Financial Strength Ratios IMCR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI

Date modified: 2026-11-07T05:36:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.